Key Quantitative Figures

  • Authorized Capital: ₹15.00 crore (1.5 crore equity shares of ₹10 each)
  • Paid-up Capital: ₹14.86 crore (1.49 crore equity shares of ₹10 each)
  • FY26 Revenue: ₹11.23 crore (declined from ₹12.46 crore in FY25)
  • FY26 Net Profit: ₹0.05 crore (declined from ₹0.45 crore in FY25)
  • Total Assets (Mar 2026): ₹11.22 crore
  • Total Borrowings: ₹21.93 crore (non-current)
  • Trade Receivables: ₹3.52 crore
  • Inventories: ₹1.01 crore
  • Cash & Bank Balances: ₹0.15 crore

AGM Details

  • Date: September 30, 2026
  • Time: 9:00 AM
  • Venue: Registered Office at Survey No.182, Yellampet Village, Medchal Mandal, Medchal District, Telangana-501401
  • Book Closure: September 24-30, 2026 (both days inclusive)
  • Cut-off Date for E-voting: September 23, 2026

Agenda Items

Ordinary Business

1. Adoption of audited financial statements for FY ended March 31, 2026

2. Reappointment of Mr. A. Sai Balaji Krishna Teja (DIN: 07003946) as Non-Executive Director retiring by rotation

Special Business

3. Continuation of Mrs. Padma Ghanakota (DIN: 07078176) as Non-Executive and Non-Independent Director

  • Required under SEBI Regulation 17(1D)
  • Originally appointed on March 25, 2015
  • Proposed continuation for 5 years from April 1, 2026
  • Ordinary Resolution required

4. Reappointment of Mr. Bhagat Reddy Dundumulla (DIN: 07087331) as Managing Director

  • Current term expires September 6, 2026
  • Proposed reappointment for 5 years from September 7, 2026
  • Remuneration to be decided by Board within Schedule V limits
  • Special Resolution required
  • Currently drawing no remuneration "keeping in mind the interest of the company"
  • Holds 200,000 equity shares in the company

Financial Performance Highlights

| Particulars (₹ lakhs) | 2025-26 | 2024-25 | 2023-24 |

| Turnover | 1123.33 | 1245.96 | 1210.84 |

| Net Profit after Tax | 5.33 | 44.96 | 41.84 |

Corporate Structure

Board Composition: 6 Directors (3 Independent, 1 Executive, 2 Non-Executive)

Key Managerial Personnel:

  • Mr. Bhagat Reddy Dundumulla - Managing Director
  • Mrs. S Vijayagowri Satyabhavani - CFO (appointed w.e.f. February 24, 2026)
  • Mr. T. Abhilash - Company Secretary & Compliance Officer

Board Committees:

  • Audit Committee: Mr. Rajesh Kakkera (Chairman), Mr. M. Madhavarao, Mr. Addagarla Tarun
  • Nomination & Remuneration Committee: Mr. Rajesh Kakkera (Chairman), Mr. M. Madhavarao, Mr. Addagarla Tarun
  • Stakeholders Relationship Committee: Mr. M. Madhavarao (Chairman), Mr. Rajesh Kakkera, Mrs. Padma Ghanakota

Auditors:

  • Statutory: M/s. M.M. Reddy & Co., Chartered Accountants
  • Secretarial: M/s. Chakravarthy & Associates, Practicing Company Secretary
  • Internal: M/s. K.R. Shekhar & Co., Chartered Accountants

Regulatory and Compliance Matters

SAT Order for Listing Restoration

The Hon'ble Securities Appellate Tribunal, Mumbai directed restoration of the company's listing status on BSE Limited vide order dated April 17, 2025, which had been revoked by BSE Delisting Committee order dated November 28, 2024.

Secretarial Audit Qualifications

M/s. Chakravarthy & Associates reported 10 significant compliance deficiencies:

1. Non-compliance with Regulation 47(1) of SEBI LODR - financial results not published in newspapers

2. Missing independence declarations from Independent Directors

3. Non-production of Board and Committee meeting records for audit

4. Failure to intimate BSE about Board meetings

5. Non-maintenance of statutory registers

6. Missing DIR-8 and MBP-1 disclosures from directors

7. Independent Directors not registered/renewed with IICA databank

8. Non-conduct of annual performance evaluation of Board and directors

9. Missing acknowledgments of meeting notice dispatches

10. Non-maintenance of attendance registers for meetings

Statutory Dues Outstanding

  • TDS Payable: ₹48.46 lakhs
  • Professional Tax Payable: ₹7.20 lakhs
  • PF & ESI Payable: ₹2.32 lakhs
  • Total: ₹57.98 lakhs

E-voting Arrangements

  • Remote e-voting period: September 27, 2026 (9:00 AM) to September 29, 2026 (5:00 PM)
  • Service provider: Central Depository Services (India) Limited
  • Scrutinizer: M/s. Chakravarthy & Associates
  • Results declaration: On or after AGM, to be placed on company website and BSE within 2 days

Capital Structure Impact

The reappointment of directors does not involve any change in the capital structure. The company has not proposed any dividend for FY26.

Related Party Transactions

Significant outstanding loans to related parties:

  • Sri Siri Constructions (Director interested entity): ₹12.80 crore
  • Mr. Balagopal: ₹5.74 crore
  • Mrs. Padma Ghanakota: ₹0.32 crore

Operational Details

  • Business: Manufacturing of medical disposables/surgical products under "SAFTI" brand
  • Product range: IV sets, disposable syringes, needles, catheters, cannulas, Ayurvedic and nutraceutical products
  • Production capacity: IV sets (40 million), Syringes (264 million), Needles (135 million) per annum
  • Employee strength: 54 permanent employees
  • Factory locations: Medchal District and Karimnagar District, Telangana

Forward-looking Statements

The management cited expansion mode and upfront spending as reasons for minimal profits, expecting improved financial position in next 2-3 years. The company is working to revoke suspension from BSE under new management.